CAP with no comorbidities, receive what ABX?

Prepare for the Adult-Gerontology Acute Care Nurse Practitioner Test. Study with interactive quizzes and detailed explanations. Boost your exam readiness with our diverse question formats and in-depth content coverage.

Multiple Choice

CAP with no comorbidities, receive what ABX?

When treating community-acquired pneumonia in an outpatient adult with no comorbidities, the goal is to cover the typical bacteria like Streptococcus pneumoniae as well as atypical pathogens such as Mycoplasma and Chlamydophila. A macrolide, such as clarithromycin, fits this need well because it has reliable activity against both typical and atypical organisms and is suitable for outpatient use in otherwise healthy patients. Amoxicillin targets typical bacteria but lacks coverage of atypicals, so it isn’t as appropriate as a sole option here. Doxycycline also covers atypicals and S. pneumoniae and is a reasonable alternative, but the macrolide remains a common first-line choice in this scenario. Levofloxacin provides broad coverage, including atypicals and typicals, but its use is generally reserved for more severe disease or when other options aren’t suitable due to concerns about resistance and side effects in uncomplicated outpatients. So, for a healthy outpatient with CAP, a macrolide like clarithromycin is a solid first-line choice because it covers the usual pathogens, including atypicals, with appropriate safety and stewardship considerations.

When treating community-acquired pneumonia in an outpatient adult with no comorbidities, the goal is to cover the typical bacteria like Streptococcus pneumoniae as well as atypical pathogens such as Mycoplasma and Chlamydophila. A macrolide, such as clarithromycin, fits this need well because it has reliable activity against both typical and atypical organisms and is suitable for outpatient use in otherwise healthy patients.

Amoxicillin targets typical bacteria but lacks coverage of atypicals, so it isn’t as appropriate as a sole option here. Doxycycline also covers atypicals and S. pneumoniae and is a reasonable alternative, but the macrolide remains a common first-line choice in this scenario. Levofloxacin provides broad coverage, including atypicals and typicals, but its use is generally reserved for more severe disease or when other options aren’t suitable due to concerns about resistance and side effects in uncomplicated outpatients.

So, for a healthy outpatient with CAP, a macrolide like clarithromycin is a solid first-line choice because it covers the usual pathogens, including atypicals, with appropriate safety and stewardship considerations.

More practice questions